Difference between revisions of "ISMRM/QIBA PDFF Biomarker Ctte"
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
− | :Co-chairs: | + | :Co-chairs: Diego Hernando, PhD; Houchun (Harry) Hu, PhD |
:ISMRM Staff Support: Roberta A. Kravitz; Anne Marie Kahrovic | :ISMRM Staff Support: Roberta A. Kravitz; Anne Marie Kahrovic | ||
* [https://docs.google.com/spreadsheets/d/e/2PACX-1vQZBtnrVMpQOU8BEKlY_4hs21JQoEhq_926-HCFtPm77AHzJ3-dp_S6cedeDfbIIILljxJVongZMJsb/pubhtml?gid=1460430101&single=true Roster] | * [https://docs.google.com/spreadsheets/d/e/2PACX-1vQZBtnrVMpQOU8BEKlY_4hs21JQoEhq_926-HCFtPm77AHzJ3-dp_S6cedeDfbIIILljxJVongZMJsb/pubhtml?gid=1460430101&single=true Roster] |
Revision as of 21:29, 26 January 2023
- Co-chairs: Diego Hernando, PhD; Houchun (Harry) Hu, PhD
- ISMRM Staff Support: Roberta A. Kravitz; Anne Marie Kahrovic
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. This effort is supported by ISMRM, using the QIBA Process for Profile development.
Meetings
Approved call summaries:
Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on February 3, 2022.
PDFF Biomarker Committee Call Summaries Archive